Form D · Other Health Care
Orca BioSystems Inc
Menlo Park, CA · CIK 0001720544
Offering snapshot reported Jul 9, 2020 · SEC filing
- Reported sold
- $192M Offering amount: $192M
- Investors reported
- 11 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Nov 29, 2019 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 9, 2020 | Initial | $191,999,870 | No comparison | 11 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-370565
Series D Preferred Stock; Common Stock issuable upon conversion
Source: Form D, filed Jul 9, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Ivan Dimov | Director, Executive |
| Nathaniel Fernhoff | Director, Executive |
| Alex Kolicich | Director |
| Jonathan Mac Quitty | Director |
Issuer details
Industry: Other Health Care (See others in industry)
Address:
3475 Edison Way Suite C
Menlo Park, CA, 94025
Menlo Park, CA, 94025